ОСОБЕННОСТИ ТЕЧЕНИЯ ВНЕБОЛЬНИЧНОГО ПНЕВМОНИИ У ДЕТЕЙ ДОШКОЛЬНОГО ВОЗРАСТА В ЗАВИСИМОСТИ ОТ ВАКЦИНОПРОФИЛАКТИКИ
Keywords:
Pneumonia, vaccine prevention, pneumococcal infection, children, preschool age, coughAbstract
Today, one of the important problems in pediatrics is the difficulty in diagnosing and selecting adequate therapy for community-acquired pneumonia in children. The course of community-acquired pneumonia in preschool children depending on vaccine prophylaxis. The most common clinical and morphological form of pneumonia in children at the present stage is focal right-sided pneumonia with a moderate course and localization in the middle lobe (segments 4 and 5 of the lungs). For those who have not been vaccinated, pneumonia is more likely to have a severe course with long-lasting febrile body temperature, severe local symptoms and pronounced laboratory changes. The risk of development and course of community-acquired pneumonia in preschool children who have not received vaccine prophylaxis against pneumococcal infection.
References
Пневмококковые вакцины: документ по позиции ВОЗ, 2012 год. Еженедельный бюллетень, 6 апреля 2012 г., 87-й год № 14. 2012;87:129-144. (Pneumococcal vaccines: WHO position paper, 2012. Weekly Bulletin, April 6, 2012, 87th Year No. 14. 2012; 87:129-144.)
Козлов Р.С., Кречикова О.И. и др. Результаты исследования распространенности в России внебольничной пневмонии и острого среднего отита у детей в возрасте до 5 лет (PAPIRUS). Роль S. pneumoniae и H. influenzae в этиологии данных заболеваний. Клиническая микробиология и антимикробная химиотерапия. 2013;15(4):246-260. (Kozlov R.S., Krechikova O.I. and others. Results of a study of the prevalence in Russia of community-acquired pneumonia and acute otitis media in children under 5 years of age (PAPIRUS). The role of S. pneumoniae and H. influenzae in the etiology of these diseases. Clinical microbiology and antimicrobial chemotherapy. 2013;15(4):246-260)
Иммунизация пневмококковой вакциной: Методические рекомендации. -М.: МЗиСР 2008 (Immunization with pneumococcal vaccine: Guidelines. -M.: MZiSR 2008)
Сидоренко С.В., Лобзин Ю.В., Харит С.М., Королева И.С., Таточенко В.К. Пневмококковая инфекция и возможности ее профилактики - эпидемиологический обзор ситуации в мире и в России. Вопросы современной педиатрии. 2010; 9(1):54-61(Sidorenko S.V., Lobzin Yu.V., Kharit S.M., Koroleva I.S., Tatochenko V.K. Pneumococcal infection and the possibilities of its prevention - an epidemiological review of the situation in the world and in Russia. Issues of modern pediatrics. 2010;9(1):54-61)
Эпидемиология и вакцинопрофилактика инфекции, вызываемой Streptococcus pneumoniae. Методические рекомендации МР 3.3.1.0027-11 (утв. Федеральной службой по надзору в сфере защиты прав потребителей и благополучия человека 20 июля 2011 г.). -М., 2011 (Epidemiology and vaccine prevention of infection caused by Streptococcus pneumoniae. Methodological recommendations MR 3.3.1.0027-11 (approved by the Federal Service for Supervision of Consumer Rights Protection and Human Welfare on July 20, 2011). M., 2011).
Bocchini JA. Jr. et al. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). Pediatrics. 2010; 126:186-190.
Johnson HL. et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Medicine. 2010,7: e1000348.
Russel F. et al. 2011. Global review of the distribution of pneumococcal disease by age and region. SAGE meeting, 8-10 November 2011. URL: http://www.who.int/immunization/sage/6_Russel_review_age_specific_epidemiology_PCV_schedules_session_ nov11.pdf, accessed March 2012.
Saux N.L., Robinson J.L. Pneumonía in healthy Canadian children and youth: Practice points for management// J Paediatr Child Health. 2011; 16 (7). -P.417-420.
